The MAPK and AKT/mTOR pathways are generally disrupted in HCC, while the Wnt pathway, a canonical cancer-related pathway, is up-regulated in many cases of early HCC [17,18,19]. The gene discussed is MTOR; the disease is hepatocellular carcinoma.